Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Net Cash Flow: 2009-2024

Historic Net Cash Flow for Sunshine Biopharma (SBFM) over the last 16 years, with Dec 2024 value amounting to -$5.6 million.

  • Sunshine Biopharma's Net Cash Flow fell 950.21% to -$770,559 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year increase of 64.57%. This contributed to the annual value of -$5.6 million for FY2024, which is 7.38% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Net Cash Flow of -$5.6 million as of FY2024, which was up 7.38% from -$6.0 million recorded in FY2023.
  • Over the past 5 years, Sunshine Biopharma's Net Cash Flow peaked at $19.6 million during FY2022, and registered a low of -$6.0 million during FY2023.
  • Over the past 3 years, Sunshine Biopharma's median Net Cash Flow value was -$5.6 million (recorded in 2024), while the average stood at $2.7 million.
  • As far as peak fluctuations go, Sunshine Biopharma's Net Cash Flow skyrocketed by 1,722.08% in 2022, and later plummeted by 130.65% in 2023.
  • Over the past 5 years, Sunshine Biopharma's Net Cash Flow (Yearly) stood at $949,763 in 2020, then grew by 13.24% to $1.1 million in 2021, then skyrocketed by 1,722.08% to $19.6 million in 2022, then crashed by 130.65% to -$6.0 million in 2023, then rose by 7.38% to -$5.6 million in 2024.